Inter Pharma PCL (BKK:IP)

Inter Pharma PCL Balance Sheet

Financials in millions THB. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	302.44	184.6	412.39	776.42	173.87	152.33
Short-Term Investments	1	0.93	0.86	0.83	0.8	0.77
Cash & Short-Term Investments	303.43	185.53	413.25	777.25	174.67	153.09
Cash Growth	38.35%	-55.10%	-46.83%	344.99%	14.09%	-55.34%
Accounts Receivable	359.03	376.06	337.32	340.3	258.11	124.38
Other Receivables	83.29	71.37	87.74	51.89	34.08	31.49
Receivables	442.32	447.43	425.06	392.2	292.25	155.93
Inventory	356.78	339.49	351.82	332.98	192	107.65
Other Current Assets	7.14	9.35	12.72	12.78	7.7	0.61
Total Current Assets	1,110	981.8	1,203	1,515	666.61	417.28
Property, Plant & Equipment	1,187	1,150	929.27	880.77	457.32	255.39
Long-Term Investments	40.55	41.78	43.37	9.35	10.12	-
Goodwill	563.1	477.85	477.85	477.85	22.16	22.16
Other Intangible Assets	215.81	204.46	197.36	167.79	55.1	48.58
Long-Term Deferred Tax Assets	20.12	20.17	15.91	9.81	8.98	3.38
Other Long-Term Assets	61.99	144.42	85.75	29.52	106.76	9.5
Total Assets	3,201	3,021	2,952	3,090	1,327	756.33
Accounts Payable	208.88	184.6	200.52	193.79	69.65	58.49
Accrued Expenses	49.86	46.03	47.06	34.74	15.92	11.69
Short-Term Debt	119.33	79.91	46.34	48.73	131.01	11.01
Current Portion of Long-Term Debt	64	55.2	54.43	72.51	35.62	15.53
Current Portion of Leases	31.64	26.64	38.89	30.46	0.57	0.64
Current Income Taxes Payable	13.65	11.84	4.11	25.18	14.8	8.4
Current Unearned Revenue	9.4	4.59	-	-	-	-
Other Current Liabilities	124.6	117.47	87.39	92.55	68.06	54.58
Total Current Liabilities	621.36	526.29	478.75	497.95	335.63	160.35
Long-Term Debt	138.98	167.19	205.46	319.61	187.06	90.91
Long-Term Leases	61.2	65.5	54.83	67.69	1.9	2.47
Pension & Post-Retirement Benefits	47.27	40.88	32.75	31.14	15.41	8.54
Long-Term Deferred Tax Liabilities	56.21	58.22	59.21	55.33	3.53	7.62
Other Long-Term Liabilities	11.17	8.32	3.66	2.14	-	-
Total Liabilities	936.19	866.4	834.65	973.86	543.54	269.89
Common Stock	302.67	302.67	186.26	186.26	149.01	103
Additional Paid-In Capital	1,498	1,498	1,498	1,498	492.09	304.98
Retained Earnings	228.73	132.41	225.25	238.26	116.85	58.16
Comprehensive Income & Other	3.7	3.7	3.7	3.7	3.7	3.7
Total Common Equity	2,033	1,937	1,913	1,926	761.64	469.85
Minority Interest	231.64	217.4	204.53	190.25	21.86	16.59
Shareholders' Equity	2,265	2,154	2,118	2,116	783.5	486.44
Total Liabilities & Equity	3,201	3,021	2,952	3,090	1,327	756.33
Total Debt	415.14	394.45	399.95	539	356.17	120.57
Net Cash (Debt)	-111.71	-208.92	13.3	238.25	-181.5	32.53
Net Cash Growth	-	-	-94.42%	-	-	-90.25%
Net Cash Per Share	-0.18	-0.35	0.02	0.45	-0.38	0.07
Filing Date Shares Outstanding	605.34	605.34	605.35	605.35	484.27	468.65
Total Common Shares Outstanding	605.34	605.34	605.35	605.35	484.27	468.65
Working Capital	488.3	455.51	724.1	1,017	330.98	256.93
Book Value Per Share	3.36	3.20	3.16	3.18	1.57	1.00
Tangible Book Value	1,254	1,254	1,238	1,281	684.38	399.11
Tangible Book Value Per Share	2.07	2.07	2.05	2.12	1.41	0.85
Land	-	333.9	327.63	327.63	183.25	117.3
Buildings	-	534.98	430.08	404.55	177.13	66.64
Machinery	-	379.84	346.66	310.51	148.3	105.7
Construction In Progress	-	174.85	57.17	15.97	0.33	1.1

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.